Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 201–250 of 3,221 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05308901	Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma	terminated	Phase 2	6	Providence Health & ServicesOTHER	1	Aug 12, 2026	clinicaltrials
NCT05859074	A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer	recruiting	Phase 1	56	Memorial Sloan Kettering Cancer CenterOTHER	1	Aug 12, 2026	clinicaltrials